Artivion, Inc. (AORT)

CTI BioPharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	37.69	53.46	58.94	39.35	55.01	61.41
Cash & Short-Term Investments	37.69	53.46	58.94	39.35	55.01	61.41
Cash Growth	-26.26%	-9.29%	49.78%	-28.47%	-10.42%	81.88%
Accounts Receivable	87.8	79.46	71.8	61.82	53.02	45.96
Other Receivables	7.96	6.43	2.34	7.76	5.09	2.79
Receivables	95.76	85.89	74.14	69.58	58.11	48.75
Inventory	81.93	79.77	81.98	74.48	76.97	73.04
Prepaid Expenses	19.54	19.26	15.81	17.55	14.75	14.3
Other Current Assets	52.38	51.7	49.8	46.37	42.86	37.09
Total Current Assets	287.3	290.08	280.67	247.33	247.7	234.59
Property, Plant & Equipment	77.04	76.13	82.18	80.53	83.24	51.65
Goodwill	245.07	240.96	247.34	243.63	250	260.06
Other Intangible Assets	156.05	156.38	172.23	182.65	201.5	227.06
Long-Term Deferred Tax Assets	0.68	1.07	1.09	1.31	2.36	1.45
Other Long-Term Assets	13.93	24.48	8.89	7.34	8.27	14.6
Total Assets	791.16	789.1	792.4	762.8	793.05	789.4
Accounts Payable	11.7	17.97	13.32	12	10.4	9.62
Accrued Expenses	32.55	40.05	32.89	28.3	24.92	21.28
Current Portion of Long-Term Debt	0.14	0.2	1.45	1.61	1.63	1.2
Current Portion of Leases	5.24	5.09	3.98	3.82	3.68	6.38
Current Income Taxes Payable	1.61	2.93	3.84	2.64	3.63	2.81
Other Current Liabilities	0.71	0.58	2.39	1.31	0.7	19.18
Total Current Liabilities	51.94	66.82	57.86	49.68	44.95	60.47
Long-Term Debt	314.61	314.15	305.53	306.5	307.49	290.47
Long-Term Leases	42.37	42.82	47.38	44.9	49.24	19.33
Long-Term Deferred Tax Liabilities	21.53	20.18	21.85	24.5	28.8	34.71
Other Long-Term Liabilities	66.46	68.92	77.99	52.9	61.84	55.71
Total Liabilities	496.91	512.9	510.62	478.47	492.32	460.69
Common Stock	0.44	0.43	0.43	0.42	0.41	0.4
Additional Paid-In Capital	388.83	376.61	355.92	337.39	322.87	316.19
Retained Earnings	-61.77	-61.27	-47.91	-17.22	1.98	20.02
Treasury Stock	-14.65	-14.65	-14.65	-14.65	-14.65	-14.65
Comprehensive Income & Other	-18.6	-24.93	-12.01	-21.61	-9.89	6.74
Shareholders' Equity	294.25	276.2	281.78	284.33	300.73	328.71
Total Liabilities & Equity	791.16	789.1	792.4	762.8	793.05	789.4
Total Debt	362.36	362.26	358.34	356.83	362.04	317.37
Net Cash (Debt)	-324.67	-308.8	-299.4	-317.48	-307.03	-255.96
Net Cash Per Share	-7.75	-7.41	-7.35	-7.93	-7.88	-6.76
Filing Date Shares Outstanding	42.7	42.05	41.23	40.56	40.12	38.96
Total Common Shares Outstanding	42.7	41.95	41.08	40.34	39.91	38.91
Working Capital	235.36	223.26	222.81	197.66	202.74	174.12
Book Value Per Share	6.89	6.58	6.86	7.05	7.54	8.45
Tangible Book Value	-106.86	-121.14	-137.79	-141.95	-150.77	-158.41
Tangible Book Value Per Share	-2.50	-2.89	-3.35	-3.52	-3.78	-4.07
Machinery	-	74.36	74.17	79.63	80.49	72.33
Leasehold Improvements	-	51.21	49.11	47.38	39.18	38.26

Updated May 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q